Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · Real-Time Price · USD
23.91
+1.35 (5.98%)
Jul 30, 2026, 3:51 PM EDT - Market open
Adaptive Biotechnologies Employees
Adaptive Biotechnologies had 624 employees as of December 31, 2025. The number of employees increased by 5 or 0.81% compared to the previous year.
Employees
624
Change (1Y)
5
Growth (1Y)
0.81%
Revenue / Employee
$493,720
Profits / Employee
-$102,330
Market Cap
3.80B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 624 | 5 | 0.81% |
| Dec 31, 2024 | 619 | -90 | -12.69% |
| Dec 31, 2023 | 709 | -81 | -10.25% |
| Dec 31, 2022 | 790 | -68 | -7.93% |
| Dec 31, 2021 | 858 | 236 | 37.94% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| RadNet | 9,276 |
| Qiagen | 5,700 |
| Sotera Health Company | 3,000 |
| NeoGenomics | 2,500 |
| GeneDx Holdings | 1,300 |
| Twist Bioscience | 979 |
| GRAIL | 910 |
| CareDx | 765 |
ADPT News
- 6 hours ago - Adaptive Biotechnologies price target raised to $27 from $25 at JPMorgan - TheFly
- 6 hours ago - Adaptive Biotechnologies price target raised to $22 from $20 at Morgan Stanley - TheFly
- 8 hours ago - Adaptive Biotechnologies price target raised to $25 from $24 at BTIG - TheFly
- 8 hours ago - Adaptive Biotechnologies price target raised to $28 from $25 at TD Cowen - TheFly
- 9 hours ago - Adaptive Biotechnologies price target raised to $25 from $22 at Guggenheim - TheFly
- 23 hours ago - Adaptive Biotechnologies reports Q2 EPS (25c), consensus (13c) - TheFly
- 23 hours ago - Adaptive Biotechnologies sees FY26 revenue $268M-$278M from MRD business - TheFly
- 23 hours ago - Adaptive Biotechnologies Earnings Call Transcript: Q2 2026 - Transcripts